Continuous Enteral Feeding for Tracheostomy Care
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It mainly focuses on nutrition around the time of tracheostomy surgery.
What data supports the effectiveness of the treatment Continuous Enteral Feeding for Tracheostomy Care?
Is continuous enteral feeding generally safe for humans?
How is the treatment 'Continuous Enteral Feeding for Tracheostomy Care' different from other treatments?
This treatment is unique because it involves continuous feeding through a tube directly into the stomach or intestines, which is different from traditional methods that often require fasting before procedures. Continuous enteral feeding helps maintain consistent nutrition and reduces the risk of underfeeding, which can lead to worse outcomes in critically ill patients.59101112
What is the purpose of this trial?
The goal of this clinical trial is to evaluate nutrition administration in the time around the tracheostomy in patients with breathing tubes. The main questions it aims to answer are:* Will continuing nutrition up to the time of surgery (tracheostomy) decrease nutrition interruptions, thereby increasing food intake?* Does continuing nutrition up to the time of surgery increase instances of food going into the lungs or lung infections?Researchers will compare patients who have nutrition withheld 6 hours prior to surgery versus those who receive nutrition up until the time of surgery to see if there are differences in food intake, instances of food entering the lungs or lung infections.
Research Team
Marcy Jordan, PhD
Principal Investigator
University at Buffalo
Eligibility Criteria
This trial is for adults over 18 in the ICU who are intubated and need a tracheostomy. It's not for those under 18, unable to consent, on comfort measures or deemed brain dead within a week of enrollment, pregnant women, or prisoners.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are assigned to either continue or withhold enteral feeds up until the time of tracheostomy
Follow-up
Participants are monitored for safety and effectiveness after treatment, focusing on aspiration pneumonia and nutritional intake
Treatment Details
Interventions
- Feeds continued
- Feeds held
Find a Clinic Near You
Who Is Running the Clinical Trial?
State University of New York at Buffalo
Lead Sponsor